Growth factor and cytokine interactions in myogenesis. Part I. The effect of TNF-a and IFN-y on IGF-I-dependent differentiation in mouse C2C12 myogenic cells

Polish Journal of Veterinary Sciences

Volumn 14, Issue 3, 2011, Pages 417-424

  Wieteska Skrzeczynska W ^a   Grzelkowska Kowalczyk, K ^a   Tokarska, J ^a   Grabiec, K ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Cyclin A; IFN ; IGF I; Myogenesis; Myogenic regulatory factors; TNF

Indexed keywords

GAMMA INTERFERON; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CELL LINE; CYTOLOGY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; MOUSE; MYOBLAST; SKELETAL MUSCLE;

ANIMALS; CELL LINE; INSULIN-LIKE GROWTH FACTOR I; INTERFERON-GAMMA; MICE; MUSCLE, SKELETAL; MYOBLASTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80053234630     PISSN: 15051773     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10181-011-0062-3     Document Type: Article

References (24)

1. Abad LW, Schmitz HR, Parker R, Roubenoff R (2002) Cytokine responses differ by compartment and wasting status in patients with HIV infection and healthy controls. Cytokine 18: 286-293. (Pubitemid 35007489)
2. Cao Y, Kumar RM, Penn BH, Berkes CA, Kooperberg C, Boyer LA, Young RA Tapscott SJ (2006) Global and gene-specific analyses show distinct roles for Myod and Myog at a common set of promoters. EMBO J 25:502-511. (Pubitemid 43237657)
3. Chen SE, Jin B, Li YP (2007) TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK. Am J Physiol Cell Physiol 292: C1660-C1671. (Pubitemid 47080547)
4. Cheng M, Nguyen MH, Fantuzzi G, Koh TJ (2008) Endogenous interferon-g is required for efficient skeletal muscle regeneration. Am J Physiol Cell Physiol 294: C1183-C1191.
5. Cheng RK, Asai T, Tang H, Dashoush NH, Kara RJ, Costa KD, Naka Y, Wu EX, Wolgemuth DJ, Chaudhry HW (2007) Cyclin A2 induces cardiac regeneration after myocardial infarction and prevents heart failure. Circ Res 100: 1741-1748. (Pubitemid 46987866)
6. Dedieu S, Mazeres G, Cottin P, Brustis JJ (2002) Involvement of myogenic regulator factors during fusion in the cell line C2C12. Int J Dev Biol 46: 235-241. (Pubitemid 34288706)
7. Dehoux M, Gobier C, Lause P, Bertrand L, Ketelslegers JM, Thissen JP (2007) IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA. Am J Physiol Endocrinol Metab 292: E145-E150. (Pubitemid 46070110)
8. Di Marco S, Mazroui R, Dallaire P, Chittur S, Tenenbaum SA, Radzioch D, Merette A, Gallouzi IE (2005) NF-kappa B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release. Mol Cell Biol 25: 6533-6545. (Pubitemid 41023228)
9. Goetsch SC, Hawke TJ, Gallardo TD, Richardson JA, Garry DJ (2003) Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration. Physiol Genomics 14: 261-271. (Pubitemid 37345234)
10. Grzelkowska-Kowalczyk K, Wieteska-Skrzeczynska W (2010) Treatment with TNF-cx and IFN-y alters the activation of Ser/Thr protein kinases and the metabolic response to IGF-I in mouse C2C12 myogenic cells. Cell Mol Biol Lett 15: 13-31.
11. Grzelkowska-Kowalczyk K, Wieteska-Skrzeczynska W (2006) Exposure to TNF-α but not IL-1B impairs insulin- dependent phosphorylation of protein kinase B and p70S6k in mouse C2C12 myogenic cells. Pol J Vet Sci 9: 1-10.
12. Ishido M, Kami K, Masuhara M (2004) In vivo expression patterns of MyoD, p21, and Rb proteins in myonuclei and satellite cells of denervatcd rat skeletal muscle. Am J Physiol Cell Physiol 287: C484-C493. (Pubitemid 38955240)
13. Karalaki M, Fili S, Philippou A, Koutsilieris M (2009) Muscle regeneration: cellular and molecular events. In Vivo 23: 779-796.
14. Kitzmann M, Carnac G, Vandromme M, Primig M, Lamb NJ, Fernandez A (1998) The muscle regulatory factors MyoD and Myf-5 undergo distinc cell cycle-specific expression in muscle cells. J Cell Biol 142: 1447-1459. (Pubitemid 28452595)
15. Langen RC, Van Der Velden JL, Schols AM, Kelders MC, Wouters EF, Janssen-Heininger YM (2004) Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. FASEB J 18: 227-237. (Pubitemid 38186242)
16. Li YP, Schwartz RJ (2001) TNF-alpha regulates early differentiation of C2C12 myoblasts in an autocrine fashion. FASEB J 15: 1413-1415.
17. Madihally SV, Toner M, Yarmush ML, Mitchell RN (2002) Interferon gamma modulates trauma-induced muscle wasting and immune dysfunction. Ann Surg 236: 649-657. (Pubitemid 35246898)
18. O'Connor JC, McCusker RH, Strle K, Johnson RW, Dantzer R, Kelley KW (2008) Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology. Cell Immunol 252: 91-110.
19. Paul AC, Rosenthal N (2002) Different modes of hypertrophy in skeletal muscle fibers. J Cell Biol 156: 751-760. (Pubitemid 34839889)
20. Saini A, Al-Shanti N, Stewart CE (2006) Waste management - cytokines, growth factors and cachexia. Cytokine Growth Factor Rev 17: 475-486. (Pubitemid 44793120)
21. Saini A, Al-Shanti N, Faulkner SH, Steward CE (2008) Proand anti-apoptotic roles for IGF-I in TNF-α-induced apoptosis: a MAP kinase mediated mechanism. Growth Factors 26: 239-253.
22. Tisdale MJ (2008) Catabolic mediators of cancer cachexia. Curr Opin Support Palliat Care 2: 256-261.
23. Tintignac LA, Lagirand J, Batonnet S, Sirri V, Leibovitch MP, Leibovitch SA (2005) Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase. J Biol Chem 280: 2847-2856. (Pubitemid 40189393)
24. Yeh SS, Blackwood K, Shuster MW (2008) The cytokine basis of cachexia and its treatment: are they ready for prime time? J Am Med Dir Assoc 9: 219-236. (Pubitemid 351598056)